Essilorluxottica (XSWX:EI) EBIT: CHF3,284 Mil (TTM As of Dec. 2025)


XSWX:EI Essilorluxottica XSWX:EI
85 GF Score
Price CHF117.00
GF Value CHF159.01
! 3 Warning Signs
View Full Analysis

What is Essilorluxottica EBIT?

Essilorluxottica XSWX:EI 85 EBIT is CHF3,284 Mil as of Dec. 2025. GuruFocus rates XSWX:EI with a GF Score™ of 85/100 and a GF Value™ of CHF159.01. The stock has 3 warning signs investors should review.

Essilorluxottica's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was CHF1,349 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3,284 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Essilorluxottica's annualized ROC % for the quarter that ended in Dec. 2025 was 3.71%. Essilorluxottica's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 28.60%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Essilorluxottica's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 4.00%.


Essilorluxottica  (XSWX:EI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Essilorluxottica's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=2581.06 * ( 1 - 22.6% )/( (53944.142 + 53713.3)/ 2 )
=1997.74044/53828.721
=3.71 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=58085.178 - 4480.573 - ( 2962.974 - max(0, 10681.34 - 10341.803+2962.974))
=53944.142

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=59622.864 - 4875.647 - ( 3307.042 - max(0, 10173.072 - 11206.989+3307.042))
=53713.3

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Essilorluxottica's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2698.636/( ( (8182.649 + max(1084.267, 0)) + (8438.369 + max(1163.623, 0)) )/ 2 )
=2698.636/( ( 9266.916 + 9601.992 )/ 2 )
=2698.636/9434.454
=28.60 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3223.724 + 3146.812 + 1008.293) - (4480.573 + 0 + 1813.989)
=1084.267

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3394.757 + 3305.175 + 1200.015) - (4875.647 + 0 + 1860.677)
=1163.623

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Essilorluxottica's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=3284.303/82116.069
=4.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Essilorluxottica EBIT Related Terms


Essilorluxottica EBIT Historical Data

* Premium members only.

The historical data trend for Essilorluxottica's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Essilorluxottica EBIT Chart

Essilorluxottica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,416.45 3,146.12 3,048.96 3,308.72 3,274.38

Essilorluxottica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,333.51 1,907.86 1,457.37 1,934.99 1,349.32

XSWX:EI vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Essilorluxottica's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essilorluxottica EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Essilorluxottica's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Essilorluxottica's EV-to-EBIT falls into.


XSWX:EI
85GF Score
Essilorluxottica XSWX:EI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Essilorluxottica EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF3,284 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of CHF3,284 Mil mean?
Essilorluxottica (XSWX:EI) has a EBIT of CHF3,284 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Essilorluxottica.
Is Essilorluxottica's EBIT too high?
Essilorluxottica's current EBIT is CHF3,284 Mil. Overall, Essilorluxottica has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Essilorluxottica's EBIT compare to ISRG and BDX?
Essilorluxottica's EBIT of CHF3,284 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Essilorluxottica. Essilorluxottica's current EBIT is CHF3,284 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Essilorluxottica stock overvalued right now?
Essilorluxottica (XSWX:EI) has a current EBIT of CHF3,284 Mil. The stock's GF Value™ is CHF159.01, compared to a current price of CHF117.00 — trading 26.4% below its estimated fair value. The current EBIT is CHF3,284 Mil. Essilorluxottica's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Essilorluxottica (XSWX:EI), the current EBIT is CHF3,284 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Essilorluxottica (XSWX:EI) Overvalued in 2026?

Based on GuruFocus' analysis, Essilorluxottica stock appears to be undervalued. The current stock price of CHF117.00 is trading 26.4% below its estimated GF Value™ of CHF159.01.

Key valuation signals for XSWX:EI:

  • EBIT: CHF3,284 Mil
  • GF Value™: CHF159.01 vs. price of CHF117.00 (26.4% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the XSWX:EI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Essilorluxottica Business Description

Address 147, Rue de Paris, Charenton-Le-Pont, Paris, FRA, 94220
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest competitor and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 37% of sales in Europe, 45% in North America, and the rest in Asia and Latin America.
85GF Score

Get the complete analysis for XSWX:EI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF117.00
Price
CHF159.01
GF Value